ZetrOZ Systems is a biotechnology company developing the latest soft tissue healing therapeutics for daily home-use. The company has deep research partnerships with the US Government to commercialize mechanobiologic, bioelectronic and pharmacotherapy systems for the delivery of Sustained Acoustic Medicine (sam®) as a breakthrough innovation for healthcare cost-reduction and joint preservation. As a global healthcare company serving millions of geriatric and active-aging patients, our proprietary medical technology platforms are specially designed and formulated for the treatment of acute and chronic musculoskeletal conditions (eg. Knee Osteoarthritis and Shoulder Tendinopathy), and our innovations are clinically proven to target drug delivery, enhance tissue recovery, accelerate the body’s natural healing processes, and relieve joint pain. With +50 global patents, +40 clinical/basic science studies, +5 regulatory FDA products on the market, ZetrOZ is changing the way healthcare is delivered daily in the home.